SPORADIC MEDULLARY MICROCARCINOMA OF THE THYROID - A RETROSPECTIVE ANALYSIS OF 80 CASES

Citation
N. Beressi et al., SPORADIC MEDULLARY MICROCARCINOMA OF THE THYROID - A RETROSPECTIVE ANALYSIS OF 80 CASES, Thyroid, 8(11), 1998, pp. 1039-1044
Citations number
33
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
10507256
Volume
8
Issue
11
Year of publication
1998
Pages
1039 - 1044
Database
ISI
SICI code
1050-7256(1998)8:11<1039:SMMOTT>2.0.ZU;2-Y
Abstract
Clinical characteristics and prognosis of 80 patients (53 women and 27 men) with sporadic medullary thyroid carcinomas (MTC), less than 1 cm in size (micro-MTC), operated on between 1971 and 1996 are reported ( 73 total and 7 partial thyroidectomies). These patients, obtained from a national database of 899 patients with MTC, were compared with 357 cases of sporadic MTC greater than 1 cm and 149 subjects with familial MTC less than 1 cm (familial micro-MTC). Median age at surgery was 52 .5 years, a distribution similar to larger sporadic MTC. Micro-MTC was identified due to elevated calcitonin (47.5%), clinically identified lymph node (10.0%.), distant metastases (6.3%) or pathologic finding a t surgery (36.2%). Diarrhea and/or flushing were observed in 6 patient s including 4 with clinically identified lymph node. Among patients wh o had lymphnode dissection at surgery (68.8%), lymph node involvement with tumor was observed in 30.9%, and was significantly more frequent in multifocal (7/11) than in unifocal micro-MTC (p < 0.03). All sporad ic micro-MTC were unilateral. Survival rate was 93.9% +/- 4.4% (SE) at 10 years, greater than that observed in sporadic macro-MTC (p = 0.04) . Normal postoperative basal calcitonin (CT) was obtained in 71.1% of micro-MTC patients versus 33.6% in sporadic macro-MTC (p < 0.01). Spor adic micro-MTC is much more frequent than expected, 15% of MTC in our series. Although specific survival rate and percentage of biological c ure in micro-MTC are significantly better than for larger tumors, the frequency of lymph node involvement, however, justifies an aggressive surgical approach including total thyroidectomy and bilateral central lymph node dissection.